au.\*:("PONTICELLI, Claudio")
Results 1 to 25 of 394
Selection :
Clinical experience with everolimus (certican) : A summaryPONTICELLI, Claudio.Transplantation. 2005, Vol 79, Num 9, pp S93-S94, issn 0041-1337, SUPArticle
Basiliximab: efficacy and safety evaluation in kidney transplantationPONTICELLI, Claudio.Expert opinion on drug safety. 2014, Vol 13, Num 3, pp 373-381, issn 1474-0338, 9 p.Article
Herpes viruses and tumours in kidney transplant recipients. The role of immunosuppressionPONTICELLI, Claudio.Nephrology, dialysis, transplantation (Print). 2011, Vol 26, Num 6, pp 1769-1775, issn 0931-0509, 7 p.Article
Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantationPONTICELLI, Claudio.Nephrology, dialysis, transplantation (Print). 2010, Vol 25, Num 1, pp 25-31, issn 0931-0509, 7 p.Article
Cyclosporin A (Sandimmun®) in nephrotic syndrome, November 5, 1990, Nice, FrancePONTICELLI, Claudio.Clinical nephrology. 1991, Vol 35, issn 0301-0430, 63 p., SUP1Conference Proceedings
Reducing exposure to calcineurin inhibitors following renal transplantation: clinical experience with everolimus (Certican)PONTICELLI, Claudio.Transplantation. 2005, Vol 79, Num 9, issn 0041-1337, 29 p., SUPSerial Issue
New recommendations in the treatment of Gram-positive bacteraemia in dialysis patientsPONTICELLI, Claudio.Nephrology, dialysis, transplantation (Print). 2008, Vol 23, Num 1, pp 27-32, issn 0931-0509, 6 p.Article
Gastrointestinal complications in renal transplant recipientsPONTICELLI, Claudio; PASSERINI, Patrizia.Transplant international. 2005, Vol 18, Num 6, pp 643-650, issn 0934-0874, 8 p.Article
Autosomal dominant polycystic kidney disease and mTOR inhibitors: the narrow road between hope and disappointmentPONTICELLI, Claudio; LOCATELLI, Francesco.Nephrology, dialysis, transplantation (Print). 2010, Vol 25, Num 12, pp 3809-3812, issn 0931-0509, 4 p.Article
Role of anaemia in cardiovascular mortality and morbidity in transplant patientsPONTICELLI, Claudio; VILLA, Margarita.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 41-46, issn 0931-0509, SUP1Conference Paper
Clinical experience with everolimus (certican) in young renal transplant recipientsERIS, Josette.Transplantation. 2005, Vol 79, Num 9, pp S89-S92, issn 0041-1337, SUPArticle
New Dimensions in Transplantation: Weaving the FutureKAHAN, Barry D; PONTICELLI, Claudio.Transplantation proceedings. 1998, Vol 30, Num 5, issn 0041-1345, 910 p.Conference Proceedings
Thrombotic microangiopathy after kidney transplantationPONTICELLI, Claudio; BANFI, Giovanni.Transplant international. 2006, Vol 19, Num 10, pp 789-794, issn 0934-0874, 6 p.Article
Introducing everolimus (certican) in organ transplantation : An overview of preclinical and early clinical developmentsNEUMAYER, Hans-Hellmut.Transplantation. 2005, Vol 79, Num 9, pp S72-S75, issn 0041-1337, SUPArticle
Concentration-controlled everolimus (certican) : Combination with reduced dose calcineurin inhibitorsPASCUAL, Julio.Transplantation. 2005, Vol 79, Num 9, pp S76-S79, issn 0041-1337, SUPArticle
The Kidney, a Victim and Culprit of Autoimmune and Alloimmune ResponsesPONTICELLI, Claudio; SALVADORI, Maurizio; COPPO, Rosanna et al.The Nephron journals. 2011, Vol 119, Num 3, issn 1660-8151, C200-C204Article
Haemophagocytic syndrome―a life-threatening complication of renal transplantationPONTICELLI, Claudio; CASA ALBERIGHI, Ornella Della.Nephrology, dialysis, transplantation (Print). 2009, Vol 24, Num 9, pp 2623-2627, issn 0931-0509, 5 p.Article
Hepatitis C virus infection and renal transplantationFABRIZI, Fabrizio; MARTIN, Paul; PONTICELLI, Claudio et al.American journal of kidney diseases. 2001, Vol 38, Num 5, pp 919-934, issn 0272-6386Article
Elderly and other suboptimal renal grafts and transplant outcomeLLOVERAS, J.Transplantation proceedings. 1998, Vol 30, Num 5, pp 2269-2271, issn 0041-1345Conference Paper
New immunosuppressive agents in pediatric renal transplantationETTENGER, R. B.Transplantation proceedings. 1998, Vol 30, Num 5, pp 1956-1958, issn 0041-1345Conference Paper
FTY720 : A new immunosuppressive agent with novel mechanism(s) of actionKAHAN, B. D.Transplantation proceedings. 1998, Vol 30, Num 5, pp 2210-2213, issn 0041-1345Conference Paper
Polymerase chain reaction methods in immunologyDALLMAN, M. J.Transplantation proceedings. 1998, Vol 30, Num 5, pp 2367-2369, issn 0041-1345Conference Paper
Cardiac transplantation : Three decades of experience define our challengeYOUNG, J. B.Transplantation proceedings. 1998, Vol 30, Num 5, pp 1885-1888, issn 0041-1345Conference Paper
Cyclosporine (CsA) in lupus nephritis : assessing the evidenceMORONI, Gabriella; DORIA, Andrea; PONTICELLI, Claudio et al.Nephrology, dialysis, transplantation (Print). 2009, Vol 24, Num 1, pp 15-20, issn 0931-0509, 6 p.Article
Clinical experience with everolimus (certican) : Optimizing dose and tolerabilityPASCUAL, Julio; MARCEN, Roberto; ORTUNO, Joaquin et al.Transplantation. 2005, Vol 79, Num 9, pp S80-S84, issn 0041-1337, SUPArticle